Testing for hypothalamic-pituitary-adrenal axis suppression in asthmatic children.
Priftis
Kostas N
KN
Papadimitriou
Anastasios
A
Nicolaidou
Polyxeni
P
Chrousos
George P
GP
D000293:Adolescent; D000304:Adrenal Cortex Function Tests / Q000009:adverse effects*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D000075202:Contraindications; D003366:Cosyntropin / Q000008:administration & dosage / Q000009:adverse effects; D015536:Down-Regulation / Q000276:immunology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000276:immunology / Q000503:physiopathology; D008797:Metyrapone / Q000008:administration & dosage / Q000009:adverse effects; D010913:Pituitary-Adrenal System / Q000276:immunology / Q000503:physiopathology; D012680:Sensitivity and Specificity; D013223:Statistics as Topic
D018927:Anti-Asthmatic Agents; D003366:Cosyntropin; D008797:Metyrapone